Bard Alex
Known title: DirectorCIK: 0001837803
Associated companies
Transaction History
| HIMS | ▲ Buy | Option Exercise | 19,707 | — | 6/6/2024 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 3/15/2024 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,448 | — | 12/15/2023 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 9/15/2023 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 6/15/2023 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 25,659 | — | 6/1/2023 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 3/15/2023 | View on chart |
| HIMS | ▼ Sell | Open Market | 69,573 | $750K | 3/2/2023 | View on chart |
| HIMS | ▼ Sell | Open Market | 2,249,536 | $24.2M | 3/2/2023 | View on chart |
| HIMS | ▼ Sell | Open Market | 15,000 | $173K | 3/1/2023 | View on chart |
| HIMS | ▼ Sell | Open Market | 485,000 | $5.6M | 3/1/2023 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 12/15/2022 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,448 | — | 9/15/2022 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 2,449 | — | 6/15/2022 | View on chart |
| HIMS | ▲ Buy | Option Exercise | 9,794 | — | 3/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Hims & Hers Appoints Regional Medical Officers for Global Growth
Hims & Hers Health has appointed regional chief medical officers to support its global expansion strategy. This move is relevant as the company continues to capture market share in the cash-pay healthcare space. The stock is currently trading near its support level, with analysts maintaining a wide range of price targets.
Hims & Hers Appoints Regional Medical Officers for Global Growth. Hims & Hers Health has appointed regional chief medical officers to support its global expansion strategy. This move is relevant as the company continues to capture market share in the cash-pay healthcare space. The stock is currently trading near its support level, with analysts maintaining a wide range of price targets.